Impact of COVID-19 on 1-Year Survival Outcomes in Hepatocellular Carcinoma: A Multicenter Cohort Study.

Shuell De Souza,Jeffrey Kahol de Jong,Ylenia Perone,Shishir Shetty,Maria Qurashi,Mathew Vithayathil,Tahir Shah,Paul Ross,Laura Temperley,Vincent S Yip,Abhirup Banerjee,Dominik Bettinger,Lukas Sturm,Helen L Reeves,Daniel Geh, James Orr,Benjamin Allen,Robert P Jones,Rohini Sharma

Cancers（2023）

引用 0|浏览9

暂无评分

摘要

Interruption of routine healthcare services because of the COVID-19 pandemic caused severe delays in HCC treatment. However, DTT did not translate to reduced survival. Longer follow is important given the delay in therapy in those receiving curative therapy.

查看译文

关键词

hepatocellular carcinoma, COVID-19, treatment, survival, pandemic, time-to-treatment

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要